SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) (the "Company" or "SciClone") today announced the expiration on August 6, 2017 of the 60 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE